B超引导下腔镜取出注射式隆乳剂的临床应用(附38例报告)
|
摘要
目的探讨利用腔镜技术联合术中B超引导取出注射式隆乳剂的可行性,总结经验并探讨临床应用价值。方法选取2015年6月—2017年6月我院采用B超引导下腔镜取出注射式隆乳剂的方法,对38例(73侧)双侧乳房接受注射隆乳剂患者进行取出术,进行回顾性研究。结果手术时间25~50分钟/侧,平均(35.0±3.6)分钟/侧。均未出现中转开刀、术后出血、感染及皮下积液等并发症,患者均感到满意。术后1~6个月复诊,超声复查显示69侧(94.5%)未发现明显的隆乳剂残留。均未扪及包块,均未出现乳头、乳晕的感觉障碍。结论腔镜技术联合B超取出注射式隆乳剂是目前理想的取出方法,它具有美容、微创、安全和精准的优势。
Objective Clinical application of endoscopic surgery combined with B-ultrasound in removal of injected breast augmentation agents, the experience and the clinical value was summarized. MethodsFrom June 2015 to June 2017, 38 cases(73 sides) of bilateral breast breasts receiving injection of augmentation were treated by B-guided guided endoscopic removal of injectable augmentation. ResultsSurgery time 25 to 50 minutes/side, an average of(35.0±3.6) minutes/side. None of the patients had any complications such as metastasis, postoperative bleeding, infection and subcutaneous effusion. All patients were satisfied. Follow-up 1 to 6 months after operation, ultrasound examination showed that 69 sides(94.5%) did not find significant long emulsion residue. no palpable mass, no nipple, areola feeling disorder. Conclusion The combination of endoscopic technique and B-ultrasound injection of injectable augmentation is the ideal method of removal, which has the advantages of beauty, minimally invasive, safe and accurate, it is worthy of clinical promotion.
Objective Clinical application of endoscopic surgery combined with B-ultrasound in removal of injected breast augmentation agents, the experience and the clinical value was summarized. MethodsFrom June 2015 to June 2017, 38 cases(73 sides) of bilateral breast breasts receiving injection of augmentation were treated by B-guided guided endoscopic removal of injectable augmentation. ResultsSurgery time 25 to 50 minutes/side, an average of(35.0±3.6) minutes/side. None of the patients had any complications such as metastasis, postoperative bleeding, infection and subcutaneous effusion. All patients were satisfied. Follow-up 1 to 6 months after operation, ultrasound examination showed that 69 sides(94.5%) did not find significant long emulsion residue. no palpable mass, no nipple, areola feeling disorder. Conclusion The combination of endoscopic technique and B-ultrasound injection of injectable augmentation is the ideal method of removal, which has the advantages of beauty, minimally invasive, safe and accurate, it is worthy of clinical promotion.
引文
[1]朱婧,朱大江,陈双全,等.微创手术取注射式隆乳剂聚丙烯酰胺水凝胶35例[J].分子影像学杂志,2014,37(4):241-244.
[2]熊丽婵.聚丙烯酰胺隆乳并发症及注射物取出术式的探讨[D].南宁:广西医科大学,2009:22-23.
[3]李彩华.腔镜下注射式隆乳剂取出术的手术配合[J].当代护士(下旬刊),2013,6(6):95-96.
[4]孙家明,李薇薇,张一鸣,等.聚丙烯酰胺水凝胶注射术后并发症原因初探[J].中国药物警戒,2006,3(2):97-99.
[5]罗静,侯康,陈丽萍,等.腔镜结合术中彩超取注射式隆乳剂的临床应用(附16例报道)[J].中国普外基础与临床杂志,2010,17(12):1286-1289.
[6]范林军,姜军,杨新华,等.腔镜技术在隆乳剂取出术中的应用:附45例报道[J].中华乳腺病杂志(电子版),2009,3(6):600-609.
[7]国家食品药品监督管理局.国家食品药品监督管理局文件关于停止生产销售和使用聚丙烯酰胺水凝胶(注射用)的通告[J].中华整形外科杂志,2006(3):5.
[8]王红燕,姜玉新,乔群.超声对聚丙烯酰胺水凝胶注射隆乳术后并发症的诊断价值[J].中华整形外科杂志,2007,23(2):97-100.
[9]罗大友.黄成,贾华华.聚丙烯酰胺水凝胶毒副作用的实验研究[J].中华整形外科杂志.2012;18(2):19-20.
[10]胡华新,刘学军,朱辉,等.聚丙烯酰胺水凝胶注射隆乳不良反应的临床观察[J].中华整形外科杂志,2002,18(2):16-17,66.
[2]熊丽婵.聚丙烯酰胺隆乳并发症及注射物取出术式的探讨[D].南宁:广西医科大学,2009:22-23.
[3]李彩华.腔镜下注射式隆乳剂取出术的手术配合[J].当代护士(下旬刊),2013,6(6):95-96.
[4]孙家明,李薇薇,张一鸣,等.聚丙烯酰胺水凝胶注射术后并发症原因初探[J].中国药物警戒,2006,3(2):97-99.
[5]罗静,侯康,陈丽萍,等.腔镜结合术中彩超取注射式隆乳剂的临床应用(附16例报道)[J].中国普外基础与临床杂志,2010,17(12):1286-1289.
[6]范林军,姜军,杨新华,等.腔镜技术在隆乳剂取出术中的应用:附45例报道[J].中华乳腺病杂志(电子版),2009,3(6):600-609.
[7]国家食品药品监督管理局.国家食品药品监督管理局文件关于停止生产销售和使用聚丙烯酰胺水凝胶(注射用)的通告[J].中华整形外科杂志,2006(3):5.
[8]王红燕,姜玉新,乔群.超声对聚丙烯酰胺水凝胶注射隆乳术后并发症的诊断价值[J].中华整形外科杂志,2007,23(2):97-100.
[9]罗大友.黄成,贾华华.聚丙烯酰胺水凝胶毒副作用的实验研究[J].中华整形外科杂志.2012;18(2):19-20.
[10]胡华新,刘学军,朱辉,等.聚丙烯酰胺水凝胶注射隆乳不良反应的临床观察[J].中华整形外科杂志,2002,18(2):16-17,66.